Shareholder Alert: The Ademi Firm investigates whether Veritex Holdings, Inc. is obtained a Fair Price for its Public Shareholders

TheAdemi Firm is investigating Veritex (NASDAQ: VBTX) for possible breaches of fiduciary duty and other violations of law in its completed transaction with Huntington (NASDAQ: HBAN). https://mma.prnewswire.com/media/2672539/Ademi_Fruchter__Logo.jpg Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to […]

Polystar unveils new brand identity as part of Elisa Industriq

Elisa Polystar, a leading provider of AI-driven Automated Network and Service Assurance solutions, has today announced its official rebranding as Polystar, marking a strategic milestone aligned with the global brand renewal of Elisa Industriq. A unified vision for operational intelligence Polystar's rebranding underscores its vital role within Elisa Industriq's unified ecosystem-alongside camLine, sedApta, CalcuQuote, TenForce,

Appian and IFC partner to launch new US$1 billion critical minerals and metals fund for emerging markets

ABU DHABI, United Arab Emirates, Oct. 21, 2025 (GLOBE NEWSWIRE) — Appian Capital Advisory Limited (“Appian”), the investment advisor to long-term value-focused private capital funds that invest in companies in metals, mining, and adjacent industries, announces the launch of a critical minerals, metals and mining fund for emerging markets (the “Fund”) in partnership with International

MTC Namibia selects VOX Solutions as its exclusive international gateway for A2P SMS and Voice traffic

MTC Namibia, the largest mobile operator in Namibia, has signed an exclusive interworking agreement with VOX Solutions for the direct termination of international A2P SMS and A2P Voice (OTP Voice/Flash Calls) traffic into its network. Through this agreement, VOX Solutions becomes the sole authorized channel for all international A2P traffic directed to MTC Namibia, effectively

Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory™

— Highly experienced hires bring robust operational and technical expertise — Momentum builds at Astraveus following exceptional additions of Jean-Paul Mangeolle, David Newble, and Laurence Riot Lamotte earlier this year Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces that it has further strengthened its world class leadership team with the

Appian and IFC partner to launch new US$1 billion critical minerals and metals fund for emerging markets

Appian and IFC partner to launch new US$1 billion critical minerals and metals fund for emerging markets GlobeNewswire October 21, 2025 ABU DHABI, United Arab Emirates, Oct. 21, 2025 (GLOBE NEWSWIRE) — Appian Capital Advisory Limited (“Appian”), the investment advisor to long-term value-focused private capital funds that invest in companies in metals, mining, and adjacent

Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO

(TSE:4565.T), HTL0039732 (also known as NXE0039732) is Nxera's novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies HTL0039732, was found to be well-tolerated, confirmed target engagement and demonstrated encouraging early efficacy in two distinct tumor types when administered in combination use with atezolizumab Phase 1

Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO

Nxera's Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO GlobeNewswire October 21, 2025 HTL0039732 (also known as NXE0039732) is Nxera's novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies HTL0039732, was found to

SiriusPoint Announces Will Nihan as IMG CEO

(NYSE:SPNT), HAMILTON, Bermuda, Oct. 21, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced the appointment of Will Nihan as Chief Executive Officer at International Medical Group (“IMG”). IMG is SiriusPoint's wholly owned subsidiary and a leader in global insurance benefits and assistance services. Mr. Nihan

SiriusPoint Announces Will Nihan as IMG CEO

SiriusPoint Announces Will Nihan as IMG CEO GlobeNewswire October 21, 2025 HAMILTON, Bermuda, Oct. 21, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced the appointment of Will Nihan as Chief Executive Officer at International Medical Group (“IMG”). IMG is SiriusPoint's wholly owned subsidiary and a

Scroll to Top